# SERPINI2

## Overview
SERPINI2 is a gene that encodes the protein serpin family I member 2, also known as pancpin, which is a serine protease inhibitor belonging to the serpin superfamily. This protein is characterized by its conserved serpin fold, which includes three β-sheets and several α-helices, allowing it to function as a protease inhibitor (SanchezNavarro2020Integrative). SERPINI2 specifically targets pancreatic elastase and chymotrypsin, playing a critical role in regulating proteolytic processes within the pancreas (Higgins2017SerpinI2). The protein is primarily expressed in the pancreas, where it is involved in maintaining tissue homeostasis by preventing premature activation of zymogens, thus protecting pancreatic cells from damage (Badola2006Correlation; Higgins2017SerpinI2). Mutations or altered expression of the SERPINI2 gene have been linked to pancreatic diseases, including pancreatic cancer and insufficiency, highlighting its significance in pancreatic health and disease (Loftus2005Acinar; Goonesekere2017Identification).

## Structure
The SERPINI2 protein, also known as pancpin, is a member of the serpin superfamily, characterized by a conserved tertiary structure known as the serpin fold, which includes three β-sheets and several α-helices (SanchezNavarro2020Integrative). This structure allows serpins to undergo conformational changes necessary for their function as protease inhibitors. SERPINI2 specifically targets pancreatic elastase and chymotrypsin (Higgins2017SerpinI2).

The protein has a metastable native structure that can transition to a more stable state upon cleavage in the reactive center loop (RCL) or when forming a complex with a target protease. This transition is facilitated by a flexible hinge region in the RCL, which includes a predicted P14 serine residue (Higgins2017SerpinI2). The thermal stability of SERPINI2 increases significantly after RCL cleavage, as demonstrated by circular dichroism spectroscopy (Higgins2017SerpinI2).

SERPINI2 is prone to polymerization under certain conditions, a characteristic shared with other serpins associated with serpinopathy diseases (Higgins2017SerpinI2). The protein's expression is restricted to the pancreas, indicating a specific physiological role (Badola2006Correlation). There is no specific information on post-translational modifications or splice variant isoforms for SERPINI2 in the provided context.

## Function
The SERPINI2 gene encodes a serine protease inhibitor that plays a crucial role in regulating proteolytic processes within the pancreas. This protein specifically inhibits pancreatic elastase and chymotrypsin, enzymes involved in the degradation of extracellular matrix components, thereby influencing cell migration, proliferation, and apoptosis (Higgins2017SerpinI2). SERPINI2 is primarily active in the zymogen granules and the Golgi complex of pancreatic acinar cells, suggesting its involvement in protein sorting and zymogen granule maturation (Loftus2005Acinar; Higgins2017SerpinI2).

In healthy cells, SERPINI2 helps maintain tissue homeostasis by preventing premature activation of zymogens, which are inactive enzyme precursors, thus protecting pancreatic cells from damage (Higgins2017SerpinI2). The protein's activity is crucial for maintaining the balance of active protease levels, which is essential for proper digestive enzyme processing and immune function (Loftus2005Acinar). SERPINI2's role in inhibiting elastase and chymotrypsin is vital for preventing acinar cell apoptosis and pancreatic insufficiency, as demonstrated in studies with mice (Higgins2017SerpinI2). Its expression is highly regulated and restricted to the pancreas, highlighting its specific physiological role in this organ (Badola2006Correlation).

## Clinical Significance
Mutations and altered expression of the SERPINI2 gene have been implicated in several diseases, particularly pancreatic cancer and pancreatic insufficiency. SERPINI2 is downregulated in pancreatic cancer, suggesting it may function as a tumor suppressor gene. Its role in inhibiting proteases like chymotrypsin and elastase is crucial, as these enzymes are involved in proteolytic cascades linked to cancer progression (Ozaki1998Isolation; Goonesekere2017Identification). The absence of SERPINI2 in mice leads to acinar cell apoptosis and pancreatic insufficiency, resulting in growth retardation and immune defects, a condition termed 'pequeño' (Loftus2005Acinar). This phenotype is inherited in an autosomal recessive pattern and can be partially corrected by reintroducing the gene or through dietary supplementation with pancreatic enzymes (Loftus2005Acinar).

SERPINI2's deficiency is also associated with immune system impairments due to malnutrition from pancreatic insufficiency, as seen in mouse models (Loftus2005Acinar). Although no direct polymorphisms in SERPINI2 have been linked to human diseases, its potential involvement in conditions like Shwachman-Diamond syndrome has been suggested (Loftus2005Acinar; Higgins2017SerpinI2).


## References


[1. (Ozaki1998Isolation) Kouichi Ozaki, Masami Nagata, Mikio Suzuki, Tsutomu Fujiwara, Yasuo Miyoshi, Osamu Ishikawa, Hiroaki Ohigashi, Shingi Imaoka, Ei-ichi Takahashi, and Yusuke Nakamura. Isolation and characterization of a novel human pancreas-specific gene,pancpin, that is down-regulated in pancreatic cancer cells. Genes, Chromosomes and Cancer, 22(3):179–185, July 1998. URL: http://dx.doi.org/10.1002/(sici)1098-2264(199807)22:3<179::aid-gcc3>3.0.co;2-t, doi:10.1002/(sici)1098-2264(199807)22:3<179::aid-gcc3>3.0.co;2-t. This article has 31 citations.](https://doi.org/10.1002/(sici)1098-2264(199807)22:3)

[2. (Higgins2017SerpinI2) Wayne J. Higgins, Gareth T. Grehan, Kieran J. Wynne, and D. Margaret Worrall. Serpini2 (pancpin) is an inhibitory serpin targeting pancreatic elastase and chymotrypsin. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1865(2):195–200, February 2017. URL: http://dx.doi.org/10.1016/j.bbapap.2016.10.013, doi:10.1016/j.bbapap.2016.10.013. This article has 6 citations.](https://doi.org/10.1016/j.bbapap.2016.10.013)

[3. (Goonesekere2017Identification) Nalin C. W. Goonesekere, Wyatt Andersen, Alex Smith, and Xiaosheng Wang. Identification of genes highly downregulated in pancreatic cancer through a meta-analysis of microarray datasets: implications for discovery of novel tumor-suppressor genes and therapeutic targets. Journal of Cancer Research and Clinical Oncology, 144(2):309–320, December 2017. URL: http://dx.doi.org/10.1007/s00432-017-2558-4, doi:10.1007/s00432-017-2558-4. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00432-017-2558-4)

[4. (Loftus2005Acinar) Stacie K Loftus, Jennifer L Cannons, Arturo Incao, Evgenia Pak, Amy Chen, Patricia M Zerfas, Mark A Bryant, Leslie G Biesecker, Pamela L Schwartzberg, and William J Pavan. Acinar cell apoptosis in serpini2-deficient mice models pancreatic insufficiency. PLoS Genetics, 1(3):e38, September 2005. URL: http://dx.doi.org/10.1371/journal.pgen.0010038, doi:10.1371/journal.pgen.0010038. This article has 19 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.0010038)

[5. (Badola2006Correlation) Sunita Badola, Heidi Spurling, Keith Robison, Eric R. Fedyk, Gary A. Silverman, Jochen Strayle, Rosana Kapeller, and Christopher A. Tsu. Correlation of serpin–protease expression by comparative analysis of real-time pcr profiling data. Genomics, 88(2):173–184, August 2006. URL: http://dx.doi.org/10.1016/j.ygeno.2006.03.017, doi:10.1016/j.ygeno.2006.03.017. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ygeno.2006.03.017)

[6. (SanchezNavarro2020Integrative) Andrea Sanchez-Navarro, Isaac González-Soria, Rebecca Caldiño-Bohn, and Norma A. Bobadilla. Integrative view of serpins in health and disease: the contribution of serpina3. American Journal of Physiology-Cell Physiology, October 2020. URL: http://dx.doi.org/10.1152/ajpcell.00366.2020, doi:10.1152/ajpcell.00366.2020. This article has 37 citations.](https://doi.org/10.1152/ajpcell.00366.2020)